Governance Roche Holding AG Swiss Exchange

ROG

CH0012032048

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 15:51:31 16/04/2026 BST			5-day change	1st Jan Change
313.25 ^CHF	-1.18%		+0.92%	-4.36%

01:41pm	Roche to Buy Cancer-focused Saga Diagnostics for Up to $595 Million	MT
01:26pm	Roche Plans New Trial for Muscular Dystrophy Therapy to Seek EU Approval	DJ

Executive Committee: Roche Holding AG

Manager

Positions heldSince

Thomas Schinecker

51 year

Chief Executive Officer

14/03/2023

Alan Hippe

59 year

Director of Finance/CFO

05/06/2011

Pascale Schmidt

53 year

Compliance Officer

31/12/2019

Wafaa Mamilli

59 year

Chief Tech/Sci/R&D Officer

09/02/2025

Claudia Boeckstiegel

62 year

General Counsel

31/03/2020

Cristina Wilbur

59 year

Human Resources Officer

Levi Garraway

58 year

Chief Tech/Sci/R&D Officer

31/12/2022

Per-Olof Attinger

66 year

Corporate Secretary

Bruno Eschli

Investor Relations Contact

31/07/2014

Composition of the Board of Directors: Roche Holding AG

Director

CommitteesSince

Severin Schwan

59 year

Chairman

14/03/2023

André Hoffmann

67 year

Governance Committee	31/12/1995
Nominating Committee	31/12/1995
Compensation Committee Chair	31/12/1995
Compensation Committee	31/12/1995
Governance Committee Chair	31/12/1995

Anita Hauser

57 year

Compensation Committee	13/03/2017
Nominating Committee	13/03/2017

Joerg Duschmale

42 year

Audit Committee	16/03/2020
Compensation Committee Chair	16/03/2020

Ulf Mark Schneider

61 year

Audit Committee	28/02/2023
Governance Committee	30/09/2014

Akiko Iwasaki

56 year

Governance Committee

28/02/2023

Jemilah Mahmood

67 year

Governance Committee

28/02/2022

Patrick Frost

58 year

Audit Committee Chair

16/03/2020

Richard P. Lifton

73 year

Director/Board Member	02/03/2015
Independent Dir/Board Member	02/03/2015

Latest Appointments: Roche Holding AG

03-12	Poolbeg Pharma plc Appoints Adrian Kilcoyne to Scientific Advisory Board	CI
03-10	MBX Biosciences, Inc. Appoints Karen Basbaum As Chief Business Officer	CI
03-10	Roche Holding Ag Elects Lubomira Rochet to the Board of Directors	CI
03-03	Roche Holding AG Appoints Olalla Grau as Its New CEO in Sweden, Effective 1 April 2026	CI
02-26	Keros Therapeutics, Inc. Announces Board Changes, Effective March 9, 2026	CI
02-26	CEO of World Economic Forum quits after Epstein ties come to light	RE
02-26	CEO of World Economic Forum quits after Epstein ties come to light	RE

More news

Former Officers and Directors: Roche Holding AG

Insider

Positions held

SinceUntil

Christoph Franz

Chairman	28/02/2014	14/03/2023
Independent Dir/Board Member	28/02/2014	14/03/2023

Nicolas Dunant

Public Communications Contact

31/01/2019

30/04/2022

William Pao

Corporate Officer/Principal

30/04/2014

17/03/2022

Paul Bulcke

Director/Board Member	05/06/2011	31/12/2021
Independent Dir/Board Member	05/09/2011	14/03/2012

Gottlieb A. Keller

General Counsel	12/01/2010	30/03/2020
Corporate Secretary	31/12/2007	30/03/2020

John Bell

Director/Board Member	16/09/2009	16/03/2020
Independent Dir/Board Member	31/03/2011	11/09/2011
Corporate Officer/Principal	31/12/2000	16/09/2009

Andreas Oeri

Director/Board Member	12/01/2010	16/03/2020
Independent Dir/Board Member	05/09/2011	16/03/2020
Corporate Officer/Principal	31/12/1995	12/01/2010

Stephan Feldhaus

Public Communications Contact

07/09/2010

29/09/2019

Peter Voser

Director/Board Member	31/01/2011	29/06/2019
Independent Dir/Board Member	05/09/2011	14/03/2012

John Reed

Corporate Officer/Principal

01/04/2013

01/04/2018

Roland Diggelmann

Corporate Officer/Principal

31/12/2011

31/12/2017

Pius Baschera

Director/Board Member	12/01/2010	30/03/2017
Independent Dir/Board Member	05/09/2011	11/09/2011

DeAnne Shirley Julius

Director/Board Member	12/01/2010	29/02/2016
Independent Dir/Board Member	05/09/2011	29/02/2016
Corporate Officer/Principal	31/12/2001	12/01/2010

Beatrice Weder di Mauro

Director/Board Member	12/01/2010	29/02/2016
Independent Dir/Board Member	28/07/2011	11/09/2011

Silvia Ayyoubi

Human Resources Officer

12/01/2010

30/12/2015

Bernard Poussot

Director/Board Member	02/03/2015	-
Independent Dir/Board Member	02/03/2015	-

Hyam Levitsky

Corporate Officer/Principal

31/07/2011

31/01/2015

Michael Varney

Corporate Officer/Principal

31/12/2014

Richard Scheller

Corporate Officer/Principal

31/12/2008

30/12/2014

William Burns

Director/Board Member	28/02/2010	03/03/2014
Independent Dir/Board Member	28/02/2010	14/03/2012

Franz Humer

Chairman

05/09/2011

03/03/2014

Lodewijk J. R. de Vink

Director/Board Member	12/01/2010	04/03/2013
Independent Dir/Board Member	10/04/2011	11/09/2011
Corporate Officer/Principal	31/12/2003	12/01/2010

Bruno Gehrig

Director/Board Member	31/12/2003	04/03/2013
Independent Dir/Board Member	31/12/2003	14/03/2012

Jean-Jacques Garaud

Corporate Officer/Principal

31/12/2006

29/06/2012

Klaus Gustav Strein

Corporate Officer/Principal

13/09/2011

Erich Hunziker

Director/Board Member	17/01/2011	17/01/2011
Chief Tech/Sci/R&D Officer	12/01/2010	30/03/2011
Director of Finance/CFO	30/09/2001	30/03/2011

Wolfgang Ruttenstorfer

Director/Board Member	12/01/2010	13/12/2010
Independent Dir/Board Member	31/12/2006	31/12/2010

Walter Frey

Director/Board Member	12/01/2010	13/12/2010
Independent Dir/Board Member	31/12/2000	31/12/2010
Corporate Officer/Principal	31/12/2000	12/01/2010

David Goldstein

Corporate Officer/Principal

31/12/1993

31/12/2010

Peter Brabeck-Letmathe

Director/Board Member

28/02/2010

Arthur Levinson

Director/Board Member	28/02/2010	-
Independent Dir/Board Member	25/04/2011	11/09/2011

Eduard Enrico Holdener

Corporate Officer/Principal

31/12/1994

31/12/2006

Michael Burgess

Corporate Officer/Principal

23/10/2011

Rolf Hänggi

Director/Board Member

31/12/2005

Dirk W. Kirsten

Corporate Officer/Principal

31/12/2001

31/12/2003

Domenico Scala

Corporate Officer/Principal	31/12/1994	31/12/1999
Treasurer	31/12/1999	31/12/2002

Henri-Paul Meier

Investor Relations Contact	08/09/2011	-
Public Communications Contact	14/03/2002	-

Horst Teltschik

Director/Board Member	12/01/2010	-
Corporate Officer/Principal	31/12/2001	12/01/2010

Anton Affentranger

Director of Finance/CFO

Jürg Witmer

Public Communications Contact

31/12/1977

Vincent Charlon

Corporate Officer/Principal

31/12/1989

31/12/1997

Rolf Schläpfer

Public Communications Contact

31/12/1996

Unni Hjelmaas

Corporate Officer/Principal

31/12/1996

Gerard Farmer

General Counsel

31/12/1988

Pierre Jaccoud

Corporate Secretary

31/12/1987

Marc Salzberg

Corporate Officer/Principal

Wing-Kai Chan

Corporate Officer/Principal

Peter Boyle

Investor Relations Contact

Markus Hosang

Corporate Officer/Principal

Daniel O'Day

Corporate Officer/Principal

Eva Losert

Public Communications Contact

Simon Roitt

Corporate Officer/Principal

Ivan Melezínek

Corporate Officer/Principal

Ashok Dhanrajgir

Corporate Officer/Principal

Melanie Wolf

Public Communications Contact

Kuno Sommer

Corporate Officer/Principal

Alexander Klauser

Public Communications Contact

07/09/2010

Ann Moravick

Corporate Officer/Principal

Peter Johann

Sales & Marketing

Karl Mahler

Investor Relations Contact	-	-
Public Communications Contact	-	-

Andreas Emmenegger

Corporate Officer/Principal

Dámaso Molero

Corporate Officer/Principal

Andreas Greuter

General Counsel

Urs Jaisli

Compliance Officer

30/01/2013

Jean-Pierre Obrecht

Corporate Officer/Principal

Tim George

Sales & Marketing

Ken A. Brameld

Corporate Officer/Principal

Alexander Zehnder

Corporate Officer/Principal

Stefan Ryser

Human Resources Officer

Robert Salcedo

Corporate Officer/Principal

Tom Edward Pike

Corporate Officer/Principal

George Abercrombie

Corporate Officer/Principal

Fritz Hoffmann-la Roche

Founder

Age distribution of managers

Parity Men Women

Male	15
Female	8

Of which Executive Committee

Male	5
Female	4

Of which Directors

Male	8
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Employees

103,249

Sector

Pharmaceuticals

Calendar

07-23 - Earnings release - Q2 2026

More about the company